INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹808 Cr | ₹645 Cr | ₹481 Cr | ₹518 Cr | ₹407 Cr |
What is the latest Total Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹808 Cr |
| Mar2024 | ₹645 Cr |
| Mar2023 | ₹481 Cr |
| Mar2022 | ₹518 Cr |
| Mar2021 | ₹407 Cr |
How is Total Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹808 Cr | 25.25 | |
| Mar2024 | ₹645 Cr | 34.26 | |
| Mar2023 | ₹481 Cr | -7.21 | |
| Mar2022 | ₹518 Cr | 27.34 | |
| Mar2021 | ₹407 Cr | - | |
Compare Total Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,942.5 Cr | 7.4% | 0.6% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 7.4% |
0.6% |
-13.7% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses